PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34940303-11	2021	Meanwhile, the levels of nuclear factor kappa beta, interleukins 6 and 1 beta, and tumour necrosis alpha (NF-kB, IL-6, IL-1beta, and TNF-alpha, respectively) were lower for ABX-NS compared to free ABX (p < 0.05).	Ambroxol	173-176	interleukin 6	Homo sapiens	52-77	
34940303-11	2021	Meanwhile, the levels of nuclear factor kappa beta, interleukins 6 and 1 beta, and tumour necrosis alpha (NF-kB, IL-6, IL-1beta, and TNF-alpha, respectively) were lower for ABX-NS compared to free ABX (p < 0.05).	Ambroxol	173-176	interleukin 6	Homo sapiens	113-117	
34940303-11	2021	Meanwhile, the levels of nuclear factor kappa beta, interleukins 6 and 1 beta, and tumour necrosis alpha (NF-kB, IL-6, IL-1beta, and TNF-alpha, respectively) were lower for ABX-NS compared to free ABX (p < 0.05).	Ambroxol	197-200	interleukin 6	Homo sapiens	52-77	
23856970-5	2014	Ambroxol (100 nM) reduced RV14 titers and cytokine concentrations of interleukin (IL)-1beta, IL-6 and IL-8 in the supernatants and RV14 RNA in the cells after RV14 infection, in addition to reducing susceptibility to RV14 infection.	Ambroxol	0-8	interleukin 6	Homo sapiens	93-97	
25174313-6	2014	Treatment with high doses of ambroxol appeared to reduce serum tumor necrosis factor-alpha level (WMD -7.92 microg/L; 95% CI, -10.94 to -4.9) and interleukin-6 level (WMD = -20.65 microg/L, 95% CI: -24.74 to -16.55) and to increase serum superoxide dismutase level (WMD = 19.07 NU/mL, 95% CI: 6.16-31.97).	Ambroxol	29-37	interleukin 6	Homo sapiens	146-159